TGF-β produced by Tregs can suppress allergic responses and prevent colitis in inflammatory bowel disease (IBD) models (50, 51), and IL-35, another inhibitory cytokine, is required for maximal Treg suppressive activity (52). Here, TGFB1 is linked to colitis.